BIOVIE INC (BIVI) Fundamental Analysis & Valuation

NASDAQ:BIVI • US09074F5044

Current stock price

1.33 USD
-0.03 (-2.21%)
Last:

This BIVI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. BIVI Profitability Analysis

1.1 Basic Checks

  • BIVI had negative earnings in the past year.
  • In the past year BIVI has reported a negative cash flow from operations.
  • BIVI had negative earnings in each of the past 5 years.
  • BIVI had a negative operating cash flow in each of the past 5 years.
BIVI Yearly Net Income VS EBIT VS OCF VS FCFBIVI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -77.67%, BIVI is doing worse than 66.67% of the companies in the same industry.
  • BIVI's Return On Equity of -90.72% is in line compared to the rest of the industry. BIVI outperforms 47.21% of its industry peers.
Industry RankSector Rank
ROA -77.67%
ROE -90.72%
ROIC N/A
ROA(3y)-119.07%
ROA(5y)-705.14%
ROE(3y)-211.57%
ROE(5y)-997.19%
ROIC(3y)N/A
ROIC(5y)N/A
BIVI Yearly ROA, ROE, ROICBIVI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

  • BIVI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BIVI Yearly Profit, Operating, Gross MarginsBIVI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. BIVI Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, BIVI has more shares outstanding
  • BIVI has more shares outstanding than it did 5 years ago.
  • BIVI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BIVI Yearly Shares OutstandingBIVI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M
BIVI Yearly Total Debt VS Total AssetsBIVI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

  • BIVI has an Altman-Z score of -22.28. This is a bad value and indicates that BIVI is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of BIVI (-22.28) is worse than 85.16% of its industry peers.
  • There is no outstanding debt for BIVI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -22.28
ROIC/WACCN/A
WACCN/A
BIVI Yearly LT Debt VS Equity VS FCFBIVI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M -20M -30M -40M

2.3 Liquidity

  • BIVI has a Current Ratio of 7.25. This indicates that BIVI is financially healthy and has no problem in meeting its short term obligations.
  • BIVI has a Current ratio of 7.25. This is in the better half of the industry: BIVI outperforms 68.98% of its industry peers.
  • BIVI has a Quick Ratio of 7.25. This indicates that BIVI is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 7.25, BIVI is doing good in the industry, outperforming 69.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.25
Quick Ratio 7.25
BIVI Yearly Current Assets VS Current LiabilitesBIVI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. BIVI Growth Analysis

3.1 Past

  • BIVI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 87.03%, which is quite impressive.
EPS 1Y (TTM)87.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.17%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 60.24% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y33.11%
EPS Next 2Y72.68%
EPS Next 3Y69.51%
EPS Next 5Y60.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BIVI Yearly Revenue VS EstimatesBIVI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2031 2032 50M 100M 150M 200M 250M
BIVI Yearly EPS VS EstimatesBIVI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -200 -400 -600

More info and screens

Find the best growth stocksShow best growing peers

4

4. BIVI Valuation Analysis

4.1 Price/Earnings Ratio

  • BIVI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • The Price/Forward Earnings ratio is 0.30, which indicates a rather cheap valuation of BIVI.
  • 99.81% of the companies in the same industry are more expensive than BIVI, based on the Price/Forward Earnings ratio.
  • BIVI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.51.
Industry RankSector Rank
PE N/A
Fwd PE 0.3
BIVI Price Earnings VS Forward Price EarningsBIVI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BIVI Per share dataBIVI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

  • BIVI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BIVI's earnings are expected to grow with 69.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y72.68%
EPS Next 3Y69.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BIVI Dividend Analysis

5.1 Amount

  • No dividends for BIVI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BIVI Fundamentals: All Metrics, Ratios and Statistics

BIOVIE INC

NASDAQ:BIVI (3/27/2026, 11:03:27 AM)

1.33

-0.03 (-2.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-06
Earnings (Next)05-11
Inst Owners19.06%
Inst Owner Change8.84%
Ins Owners0.24%
Ins Owner Change0%
Market Cap10.03M
Revenue(TTM)N/A
Net Income(TTM)-17.48M
Analysts82.86
Price Target12.24 (820.3%)
Short Float %1.89%
Short Ratio1.4
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.3
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.52
P/tB 0.53
EV/EBITDA N/A
EPS(TTM)-5.13
EYN/A
EPS(NY)4.42
Fwd EY332.08%
FCF(TTM)-1.9
FCFYN/A
OCF(TTM)-1.9
OCFYN/A
SpS0
BVpS2.56
TBVpS2.5
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -77.67%
ROE -90.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-119.07%
ROA(5y)-705.14%
ROE(3y)-211.57%
ROE(5y)-997.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.25
Quick Ratio 7.25
Altman-Z -22.28
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.17%
EPS Next Y33.11%
EPS Next 2Y72.68%
EPS Next 3Y69.51%
EPS Next 5Y60.24%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y65.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y65.16%
OCF growth 3YN/A
OCF growth 5YN/A

BIOVIE INC / BIVI Fundamental Analysis FAQ

What is the fundamental rating for BIVI stock?

ChartMill assigns a fundamental rating of 3 / 10 to BIVI.


Can you provide the valuation status for BIOVIE INC?

ChartMill assigns a valuation rating of 4 / 10 to BIOVIE INC (BIVI). This can be considered as Fairly Valued.


How profitable is BIOVIE INC (BIVI) stock?

BIOVIE INC (BIVI) has a profitability rating of 0 / 10.


What is the expected EPS growth for BIOVIE INC (BIVI) stock?

The Earnings per Share (EPS) of BIOVIE INC (BIVI) is expected to grow by 33.11% in the next year.